EOOBE-Application to collect information for new computer and manufacturing process
    3.
    发明申请
    EOOBE-Application to collect information for new computer and manufacturing process 审中-公开
    EOOBE - 收集新计算机和制造过程信息的应用程序

    公开(公告)号:US20110119479A1

    公开(公告)日:2011-05-19

    申请号:US12590958

    申请日:2009-11-17

    IPC分类号: G06F1/24

    CPC分类号: G06Q10/06 G06Q50/04 Y02P90/30

    摘要: A system and method for enhancing the Electronic Out Of Box Experience (eOOBE) for individuals who are ordering a new or replacement device from the device manufacturer. The user is able to select an option to complete the eOOBE setup prior to receiving the new device, where the new device may be a computer, phone, PDA, or other electronic device. An application such as an applet is downloaded from the manufacturer and the application collects device settings and user preferences, as well as file system information, storing the information to a file on the local device file system. This gathered information may include acquiescence to Electronic User License Agreements (EULA), such that these licenses may be pre-configured with the user's agreement before the device is shipped to the user. The collected information is encrypted and sent to the manufacturer, where the manufacturer then builds and configures the new device in accordance with the received data file. The new device is delivered to the user and the user is able to operate the new device in fully configured and activated mode directly out of the manufacturers shipping container. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract.

    摘要翻译: 一种用于为从设备制造商订购新的或更换设备的个人增强电子外箱体验(eOOBE)的系统和方法。 用户能够在接收新设备之前选择完成eOOBE设置的选项,其中新设备可以是计算机,电话,PDA或其他电子设备。 从制造商下载诸如小程序的应用程序,并且应用程序收集设备设置和用户偏好以及将信息存储在本地设备文件系统上的文件的文件系统信息。 收集的信息可能包括默认电子用户许可协议(EULA),以便这些许可证可能在设备发送给用户之前用用户协议进行预先配置。 收集的信息被加密并发送到制造商,制造商然后根据接收到的数据文件构建和配置新的设备。 新设备交付给用户,用户能够直接从制造商运输集装箱中以完全配置和激活模式操作新设备。 该摘要不被认为是限制性的,因为其他实施例可能偏离本摘要中描述的特征。

    Composite product
    5.
    发明申请
    Composite product 审中-公开
    复合产品

    公开(公告)号:US20070077436A1

    公开(公告)日:2007-04-05

    申请号:US11634285

    申请日:2006-12-04

    IPC分类号: B32B9/04

    摘要: The Abstract of the Disclosure filed herewith has replaced the previous Abstract of the Disclosure that begins with the words, “A composite product comprising a substrate layer” with the following paragraph: An exemplary composite product and method of manufacturing is provided. In one embodiment, the method includes dewatering a first slurry through a dewatering belt to form a first substrate layer, applying a first functional layer onto at least a portion of the first substrate layer, and dewatering a second slurry through the dewatering belt to form a second substrate layer. A first side of the second substrate layer may be overlayed onto the first functional layer, and the layers may be cured, and the layers bonded.

    摘要翻译: 本文提交的披露摘要已经取代了以下开始于“包含基底层的复合产品”的以前的摘要摘要:提供了一种示例性的复合产品和制造方法。 在一个实施方案中,所述方法包括通过脱水带将第一浆料脱水以形成第一基材层,将第一功能层施加到第一基材层的至少一部分上,以及通过脱水带将第二浆料脱水形成 第二基板层。 第二衬底层的第一侧可以覆盖在第一功能层上,并且可以使层固化,并且层粘合。

    Triamcinolone compositions for intravitreal administration to treat ocular conditions
    6.
    发明申请
    Triamcinolone compositions for intravitreal administration to treat ocular conditions 审中-公开
    用于玻璃体内给药以治疗眼部病症的曲安奈德组合物

    公开(公告)号:US20060141049A1

    公开(公告)日:2006-06-29

    申请号:US11354415

    申请日:2006-02-14

    摘要: Triamcinolone compositions, and methods of using such compositions, useful for injection into the vitreous of human eyes are provided. Such compositions can include triamcinolone particles present in a therapeutically effective amount, a viscosity inducing component, and an aqueous carrier component. The compositions have viscosities of at least about 10 cps or about 100 cps at a shear rate of 0.1/second. In a preferred embodiment, the viscosity is in the range of from about 80,000 cps to about 300,000 cps. The compositions advantageously suspend the triamcinolone particles for prolonged periods of time.

    摘要翻译: 提供曲安奈德组合物,以及使用这些组合物的方法,其用于注射到人眼的玻璃体中。 这样的组合物可以包括以治疗有效量存在的曲安奈德颗粒,粘度诱导组分和水性载体组分。 组合物在0.1 /秒的剪切速率下具有至少约10cps或约100cps的粘度。 在优选的实施方案中,粘度在约80,000cps至约300,000cps的范围内。 组合物有利地将曲安奈德颗粒悬浮较长时间。

    Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
    7.
    发明申请
    Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods 审中-公开
    含有视网膜友好赋形剂的治疗眼用组合物及相关方法

    公开(公告)号:US20050250737A1

    公开(公告)日:2005-11-10

    申请号:US11091977

    申请日:2005-03-28

    摘要: Pharmaceutical compositions suitable for administration into the interior of an eye of a person or animal are described. The present compositions include one or more components which are effective in providing a reduced toxicity relative to existing intraocular ophthalmic compositions. The present compositions include one or more therapeutic agents in amounts effective in providing a desired therapeutic effect when placed in an eye, and one or more retinal friendly excipients that have a reduced toxicity relative to benzyl alcohol or polysorbate 80. In certain compositions, the excipient component of the compositions comprises one or more cyclodextrins or cyclodextrin derivatives. Methods of using the compositions to treat ocular conditions are also described.

    摘要翻译: 描述适于施用于人或动物的眼睛内部的药物组合物。 本发明组合物包括一种或多种有效提供相对于现有眼内眼用组合物的毒性降低的成分。 本发明的组合物包含一种或多种治疗剂,其用量在置于眼中时可提供所需的治疗效果,以及一种或多种视黄醛友好的赋形剂,其相对于苯甲醇或聚山梨酸酯80具有降低的毒性。在某些组合物中,赋形剂 组合物的组分包含一种或多种环糊精或环糊精衍生物。 还描述了使用组合物治疗眼睛病症的方法。

    Inhibition of irritating side effects associated with use of a topical ophthalmic medication

    公开(公告)号:US20050004074A1

    公开(公告)日:2005-01-06

    申请号:US10613097

    申请日:2003-07-01

    摘要: This invention relates to a method of reducing an irritating or adverse side effect associated with the topical use of an active ophthalmic drug comprising incorporating an effective amount of a cyclodextrin or cyclodextrin derivative into a formulation to complex the active drug such that the concentration of the free active drug is reduced below a tolerable threshold, and incorporating an effective amount of a viscosity increasing agent in said formulation such that the bioavailability of said drug is high enough to be therapeutically effective, wherein the cyclodextrin or cyclodextrin derivative is not required to solubilize the active drug. Another aspect of this invention relates to topical ophthalmic formulations comprising an active drug, a cyclodextrin or cyclodextrin derivative, and a viscosity-enhancing agent, in effective amounts as stated above.

    Method and system for child safety
    10.
    发明授权

    公开(公告)号:US10991225B1

    公开(公告)日:2021-04-27

    申请号:US16178863

    申请日:2018-11-02

    申请人: Robert Lyons

    发明人: Robert Lyons

    摘要: A child car seat is disclosed. The car seat has a seat form for accommodating a child. A belt for retaining a child is disposed within the child car seat. A first buckle is operable between a first open position and a second other fastened position, for when fastened fastening the belt to retain a child and for when open facilitating installation and removal of a child from the child car seat. The child car seat also has an integrated interface port for removably retaining a first electronic circuit having communication circuitry for communicating with an automobile. The interface port has electrical conductors for electrically coupling with the electrical circuitry within the first electronic circuit.